Outstanding Achievement Award

About the Award

The ASGCT Outstanding Achievement Award recognizes an ASGCT member who has achieved a pioneering research success, specific high-impact accomplishment, or lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor and the recipient is celebrated at the ASGCT Annual Meeting. The recipient presents a plenary lecture highlighting their scientific accomplishments that led to the award.

Criteria and Nominations

Any ASGCT member, other than a current officer or member of the Nomination and Awards Committee, is eligible. Nomination letters must be 500 words or fewer and be submitted by two ASGCT members. Nominees will be notified and required to provide a CV or NIH bio-sketch.

Check back to this page for information about 2025 Annual Meeting Awards!


David Liu, PhD

J. Keith Joung, MD, PhD

Donald Kohn, MD

Carl June, MD, and Michel Sadelain, MD, PhD

Mavis Agbandje-McKenna, PhD
Structure-guided AAV Vectorology

John J. Rossi, PhD, Beckman Research Institute City of Hope, Duarte CA
My 40-Year Journey to Develop RNA Base Therapies

Jean Bennett, MD, PhD, University of Pennsylvania, Philidelphia, PA
Seeing the Light with Retinal Gene Therapy: From Fantasy to Reality

Maria-Grazia Roncarolo, MD, Stanford University School of Medicine, Stanford, CA
Cell and Gene Therapy for Genetic Immunodeficiencies:  Popping the Bubble

Seppo Yla-Herttuala, MD, PhD, FESC, University of Eastern Finland
Vascular Biology and Advances in Cardiovscular and Cancer Gene Therapy From Bench to Bedside

Bruce Sullenger, PhD, Duke University Medical Center, Durham, NC
Therapeutic Aptamers from HIV Gene Therapy to the Cath Lab and Cancer

Luigi Naldini, MD, PhD, University Vita-Salute San Raffaele
Lentiviral Vectors From Bench to Bedside: A Lifetime Journey

Mark A. Kay, MD, PhD, Stanford University School of Medicine
Deciphering Vector and Non-coding RNA Biology: A New Frontier in Nucleic Acid based Therapies.

David A. Williams, MD, Children's Hospital Boston, Boston, MA
25 Years in Translation: The Hematopoietic Microenvironment and HSC Gene Therapy

Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Houston, TX
Cell and Gene Therapy - Putting it Together

Katherine A. High, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA
Gene Therapy for Genetic Disease: Hemophilia as a Paradigm

Inder Verma, PhD, The Salk Institute, La Jolla, CA
25 Years of Gene Therapy: Ups and Downs

R. Jude Samulski, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
AAVolution of a Smart Virus


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.